ABSOLUTE CONFIGURATION AND CHIRAL RECOGNITION OF (+)-9-BENZYLOXY-a-DIHYDROTETRABENAZINE
223
enantiomers. Combined with the X-ray crystal diffraction
LITERATURE CITED
structure of racemic compound 5, we could infer that com-
pound 5 consists of (R,R) and (S,S) enantiomers.
1. Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, Kung MP,
Kung HF. Pharmacokinetics of [18F]fluoroalkyl derivatives of dihydrotetra-
benazine in rat and monkey brain. Nucl Med Biol 2007;34:233–237.
Racemic compound 6 was synthesized from racemic
compound 5 and a new chiral carbon generated. Therefore,
compound 6 may contain a maximum of four isomers: a config-
uration [(R,R,R) isomer and (S,S,S) isomer] and b configura-
tion [(R,R,S) isomer and (S,S,R) isomer]. The b configuration
isomers could be removed by recrystallization.9 For this
reason, racemic compound 6 obtained by this method was a
configuration; in other words, it consists of two isomers. This
was exactly in line with the results of the chiral HPLC of race-
mic compound 6 as shown in Figure 8.
Compound 8 was obtained by the separation of racemic
compound 6. The X-ray results showed that compound
8 has the absolute configuration of a (R,R,R) isomer. However,
given the X-ray diffraction analysis of the sample only in a
single crystal, the result was not universal. The chiral HPLC
was also investigated for compound 8. There was only one
peak in the HPLC graph as shown in Figure 9. As discussed
above, compound 8 is a single configuration compound and
it has the absolute configuration of R,R,R.
2. Simpson NR, Souza F, Witkowski P, Maffei A, Raffo A, Herron A, Kilbourn
M, Jurewicz A, Herold K, Liu E, Hardy MA, Heertum RV, Harris PE. Visu-
alizing pancreatic beta-cell mass with
[
11C]DTBZ. Nucl Med Biol
2006;33:855–864.
3. Jewett DM, Kilbourn MR, Lee LC. A simple synthesis of [11C]dihydrote-
trabenazine (DTBZ). Nucl Med Biol 1997;24:197–199.
4. Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA.
Dopamine depletion increases in vivo [11C]dihydrotetrabenazine ([11C]
DTBZ) binding in rat striatum. Nucl Med Biol 2010;37:3–8.
5. Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA. Differentiating
Alzheimer’s disease from dementia with Lewy bodies and Parkinson’s
disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Alzheimers Dement 2008;4:S67–S76.
6. Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Char-
acterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a
potential PET imaging agent targeting vesicular monoamine transporters.
Nucl Med Biol 2007;34:239–246.
7. Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF.
Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission
tomography imaging agents targeting vesicular monoamine transporters.
Nucl Med Biol 2006;33:685–694.
8. Zheng PG, Lieberman BP, Choi SR, Plöessl K, Kung HF. Synthesis and
biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicu-
lar monoamine transporter-2 (VMAT2) ligands. Bioorg Med Chem Lett
2011;21:3435–3438.
CONCLUSIONS
(+)-9-benzyloxy-a-dihydrotetrabenazine (8) was synthe-
sized by a six-step reaction. The crystal organizations of race-
mic compound 5 and compound 7 were established first.
X-ray crystal diffraction and chiral HPLC indicated that com-
pound 8 consists of only one isomer and has the absolute
configuration of 2R,3R,11bR. Furthermore, two symmetry-
independent molecules were found in the crystal of racemic
compound 5. In compound 7, the (2R,3R)-(À)-di-p-toluoyl-L-
tartrate anion and the (+)-9-benzyloxy-a-dihydrotetrabenazine
cation formed a close ion pair through a carbonyl-assisted salt
bridge and the OH. . .O hydrogen bond interactions. In addi-
tion, these two interactions also created polar columns in
the crystal. The polar column was a one-dimensional supra-
molecular chain and resembled a beautiful butterfly with
open wings as viewed along the c-axis. Therefore, the
carbonyl-assisted salt bridge and the OH. . .O hydrogen bond
interactions play a key role in the chiral recognition of
compound 7. These facts clarified the chiral recognition
mechanism of compound 7 and they should be helpful in in-
vestigating the chiral recognition mechanism of the parent
structure of compound 8 for the amino acids in the VMAT2.
9. Boldt KG, Brine GA, Rehder K. Synthesis of (+)-9-O-desmethyl-
dihydrotetrabenazine, precursor for the high affinity VMAT2 imaging
pet radioligand
[
11C]-(+)-dihydrotetrabenazine. Org Prep Proced Int
2008;40:379–384.
10. Kilbourn MR, Lee LC, Heeg MJ, Jewett DM. Absolute configuration of
(+)-a-dihydrotetrabenazine, an active metabolite of tetrabenazine. Chirality
1997;9:59–62.
11. Schmiechen R, Mulzer J, Zuhse R. Enantioselective synthesis of the
antidepressant rolipram by Michael addition to a nitroolefin. Angew
Chem Int Ed Engl 1992;31:870–872.
12. Yonan PK, Grove M. 1-Aryl-3,4-dihydro-2(1H)-isoquinoline carbonyl
chlorides. US Pat 1977;4001244.
13. Roche FH, Aktiengesellschaft C. Novel tetrahydro-isoquinoline
derivatives and
1964;950159.
a process for the manufacture thereof. GB Pat
14. Sheldrick GM. SHELXS-97, program for crystal structure solution. Göttingen,
Germany: University of Göttingen; 2008.
15. Sheldrick GM. SHELXL-97, program for crystal structure solution. Göttingen,
Germany: University of Göttingen; 2008.
16. Desiraju GR. Supramolecular synthons in crystal engineering—a new
organic synthesis DOI:10.1002/anie.199523111 . Angew Chem Int Ed
Engl 1995;34:2311–2327.
17. Ichikawa A, Ono H, Echigo T, Mikata Y. Crystal structures and chiral
recognition of the diastereomeric salts prepared from 2-methoxy-2-(1-
naphthyl)propanoic acid. CrystEngComm 2011;13:4536–4548.
18. Yao Z, Wei X, Wu X, Katz JL, Kopajtic T, Greig NH, Sun H.
Preparation and evaluation of tetrabenazine enantiomers and all eight
stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors. Eur J
Med Chem 2011;46:1841–1848.
19. Yu QS, Luo WM, Deschamps J, Holloway HW, Kopajtic T, Katz JL, Brossi
A, Greig NH. Preparation and characterization of tetrabenazine enantio-
mers against vesicular monoamine transporter 2. ACS Med Chem Lett
2010;1:105–109.
ACKNOWLEDGMENTS
We are grateful for the financial support provided by the
National Natural Science Foundation of China (30970844)
and the Outstanding Professionals Foundation of Jiangsu
Health Bureau (RC2011096). This work was also additionally
supported in part by the Natural Science Foundation of
Jiangsu Province (BK2010155) and the Youth Research Foun-
dation of Jiangsu Institute of Nuclear Medicine (QN201109).
20. Liu CY, Chen ZP, Li XM, Tang J. A concise synthesis of tetrabenazine and
its crystal structure. Mol Cryst Liq Cryst 2012;557:39–49.
Chirality DOI 10.1002/chir